Bhavana Kunkalikar

Bhavana Kunkalikar

Bachelor of Pharmacy

Pharmaceutical Sciences, Pathophysiology

Bhavana Kunkalikar is a medical writer based in Goa, India. Her academic background is in Pharmaceutical sciences and she holds a Bachelor's degree in Pharmacy. Her educational background allowed her to foster an interest in anatomical and physiological sciences. Her college project work based on ‘The manifestations and causes of sickle cell anemia’ formed the stepping stone to a life-long fascination with human pathophysiology.

See more

After completing her Bachelor’s degree, she gained considerable industrial experience in the maintenance and upkeep of finished retention samples and testing of water samples from across the manufacturing facility. However, in the wake of the pandemic, her passion for scientific writing urged her to take up more writing projects. She is now a full-time content writer at a digital marketing agency in Bengaluru, India. Her pursuit to expand her horizons led her to medical writing that allowed her to amalgamate her passion for writing with her academic background.  

Her childhood dream of becoming a writer, rooted in the fascination with fairy tales and mystery thrillers, led her to play the part of the College Magazine Secretary and undertake the responsibilities of editor-in-chief. This encouraged her to participate in various college-level story writing competitions and win a handful of them, resulting in some of her first pieces of fictional write-ups.

Outside of work, she is interested in reading and writing fiction, with Stephen King being her go-to writer to read and she aspires to discover and read more writers from the technical field. She also plays the keyboard for pleasure and is admittedly bad at it.

See less

Articles from Bhavana

Immunosuppressive therapies for COVID-19 treatment

Immunosuppressive therapies for COVID-19 treatment

SARS-CoV-2 nucleocapsid antigen levels and patient outcomes

SARS-CoV-2 nucleocapsid antigen levels and patient outcomes

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

Study explores differences in the efficiency of COVID-19 vaccine boosters

Study explores differences in the efficiency of COVID-19 vaccine boosters

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Risk factors among pregnant and postpartum women with COVID-19

Risk factors among pregnant and postpartum women with COVID-19

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Preliminary study shows tecovirimat was well tolerated by patients with monkeypox

Preliminary study shows tecovirimat was well tolerated by patients with monkeypox

The incidence rate, distribution, characteristics, and outcomes of neonatal COVID-19

The incidence rate, distribution, characteristics, and outcomes of neonatal COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.